VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Más betegség

• Has inflammatory bowel disease or active uveitis
• Has a history of chronic or recurrent infectious disease
• Has hepatitis B or hepatitis C infection, human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), or active tuberculosis (TB) at screening

Egyéb

• Has non-plaque psoriasis at Screening or Day 1
• Has a known immune deficiency or is immunocompromised

• Diagnosed with Psoriatic Arthritis for 6 months or more prior to Screening
• Documented history or active signs of at least 1 confirmed lesion of plaque psoriasis and/or nail changes attributed to psoriasis
• Active PsA as defined by 3 or more swollen joints and 3 or more tender joints at Screening and Day 1
• Women must not be of childbearing potential or must agree to use a highly effective contraception during the study and for 30 days after the last dose of the study product
• Men with a partner who is of childbearing potential must agree to use condoms during the study and for 90 days after the last dose of study product